Insider Transactions in Q3 2025 at Envista Holdings Corp (NVST)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
            Aug 25                          
            2025                          
           | Stefan Nilsson President, Nobel Biocare | 
              SELL
             
                Payment of exercise price or tax liability
             | Direct | 
              804
              -1.44%
           | 
              $16,884              
              $21.12 P/Share              
           | 
| 
            Aug 25                          
            2025                          
           | Eric D. Hammes Chief Financial Officer | 
              SELL
             
                Payment of exercise price or tax liability
             | Direct | 
              7,654
              -7.33%
           | 
              $160,734              
              $21.12 P/Share              
           | 
| 
            Aug 25                          
            2025                          
           | Robert Befidi President, Diagnostics | 
              SELL
             
                Payment of exercise price or tax liability
             | Direct | 
              3,454
              -7.06%
           | 
              $72,534              
              $21.12 P/Share              
           | 
| 
            Aug 25                          
            2025                          
           | Veronica Acurio President, Orthodontics | 
              SELL
             
                Payment of exercise price or tax liability
             | Direct | 
              5,422
              -9.73%
           | 
              $113,862              
              $21.12 P/Share              
           | 
| 
            Aug 25                          
            2025                          
           | Mischa Reis SVP, Strategy & Bus. Dev. | 
              SELL
             
                Open market or private sale
             | Direct | 
              15,000
              -31.66%
           | 
              $315,000              
              $21.6 P/Share              
           | 
| 
            Jul 14                          
            2025                          
           | James Andrew Pierce Director | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              9,155
              +50.0%
           | 
              -                 
           |